Last Updated: November 5, 2026

BUPROPION Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Bupropion, and when can generic versions of Bupropion launch?

Bupropion is a drug marketed by Accord Hlthcare, Actavis Labs Fl Inc, Anbison Lab, Annora Pharma, Aurobindo Pharma Ltd, Aurobindo Pharma Usa, Chartwell Rx, Epic Pharma Llc, Granules, Graviti Pharms, Impax Labs, Invagen Pharms, Ipca Labs Ltd, Jubilant Generics, Lupin, Macleods Pharms, Ph Health, Prinston Inc, Rising, Sandoz, Sciegen Pharms, Sinotherapeutics Inc, Sun Pharm, Torrent, Twi Pharms, Watson Labs Inc, Wockhardt Ltd, Yichang Humanwell, Zhejiang Jutai Pharm, Zydus Pharms, Alembic, Apotex, Cadila Pharms Ltd, Heritage Pharma, Invatech, Micro Labs, and Senores Pharms. and is included in sixty-four NDAs.

The generic ingredient in BUPROPION is bupropion hydrochloride. There is one drug master file entry for this compound. Seventy-five suppliers are listed for this compound. Additional details are available on the bupropion hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Bupropion

A generic version of BUPROPION was approved as bupropion hydrochloride by SENORES PHARMS on February 7th, 2000.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for BUPROPION?
  • What are the global sales for BUPROPION?
  • What is Average Wholesale Price for BUPROPION?

US Patents and Regulatory Information for BUPROPION

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 205794-001 Mar 1, 2016 AB1 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Yichang Humanwell BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 211347-001 Oct 16, 2018 AB1 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Invagen Pharms BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 206556-001 Aug 26, 2016 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Graviti Pharms BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 211020-001 Jan 28, 2019 AB3 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Torrent BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 203969-001 Oct 31, 2014 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Alembic BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET;ORAL 203013-001 Jun 8, 2018 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Jubilant Generics BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 202774-002 Oct 11, 2013 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.